Comparison

EZM2302

Item no. DCC-DC10679-25mg
Manufacturer DCChemicals
CASRN 1628830-21-6
Amount 25 mg
Quantity options 100 mg 250 mg 25 mg 5 mg
Category
Type Inhibitors
Applications IC, IV
Specific against other
Purity >98%
Smiles ClC1C([H])=C([H])C(=C([H])C=1C1=NC(C2C(C([H])([H])[H])=NOC=2C([H])([H])[H])=C(C([H])([H])[H])C(=N1)N1C([H])([H])C2(C([H])([H])C([H])([H])N(C(=O)OC([H])([H])[H])C([H])([H])C2([H])[H])C1([H])[H])OC([H])([H])[C@@]([H])(C([H])([H])N([H])C([H])([H])[H])O[H]
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias EZM2302,EZM-2302,EZM 2302
Similar products 1628830-21-6
Available
Manufacturer - Applications
EZM2302 (GSK3359088) is the first potent and selective inhibitor of CARM1 enzymatic activity that exhibits anti-proliferative effects both in vitro and in vivo, in biochemical assays (IC50=6nM) with broad selectivity against histone methyltransferases.
Storage Conditions
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Molecular Weight
585, 0943
Note
For research only, not for human use!
Chemical name
(R)-2-[2-[2-Chloro-5-(2-hydroxy-3-methylamino-propoxy)-phenyl]-6-(3, 5- dimethyl-isoxazol-4-yl)-5-methyl-pyrimidin-4-yl]-2, 7-diaza-spiro[3.5]nonane-7-carboxylic acid methyl ester

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close